Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Busto Arsizio – page 2

16 clinical trials in Busto Arsizio, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Busto Arsizio at a glance
16
clinical trials
  • Not yet recruiting0
  • Research sites0
Type of trial
Recruitment status
Quick filters

16 trials in Busto Arsizio

Open in trial search

Multiple sclerosis+1

Not recruiting
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Methylprednisolone
  • Sponsor:F. Hoffmann-La Roche AG
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Ravulizumab
  • Sponsor:Alexion Pharmaceuticals Inc.
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Ocrelizumab
  • Sponsor:F. Hoffmann-La Roche AG
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Clinipace Global Limited

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Busto Arsizio

What the registry says about research in the country

01 Hematologic Oncology

Innovative research focusing on follicular lymphoma and acute myeloid leukemia, exploring combination therapies and treatment optimization strategies.

  • Maintenance therapy evaluation
  • Treatment strategies for high tumor burden
  • Relapse/refractory disease management

Studies aim to improve survival rates and reduce treatment burden through immunochemotherapy approaches.

02 Neurological Disorders

Comprehensive trials investigating various forms of multiple sclerosis and related conditions, including innovative treatments for PPMS and NMOSD.

  • Long-term safety evaluations
  • Pediatric treatment studies
  • Progressive MS management

Research focuses on disability progression prevention and novel therapeutic approaches.

03 Cardiopulmonary Research

Groundbreaking studies in heart failure and non-small cell lung cancer, examining innovative treatment approaches and surgical interventions.

  • Cardiovascular outcomes
  • Post-surgical cancer therapy
  • Disease-free survival assessment

Trials aim to improve patient outcomes through targeted therapies and preventive approaches.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.